The Food and Drug Administration (FDA) has announced the approval of remdesivir (Veklury) for the treatment of COVID-19. Gilead Sciences is the manufacturer of remdesivir, which was initially invented for the treatment of Ebola. However, studies have found mixed results of the drug in treating COVID-19.

Psychologists in Canada have been expressing concerns over a growing number of people with mental health issues this COVID winter. They think it would be dangerous if COVID anxiety turns into COVID depression. Experts advise people to take care of their mental health this winter.

Two commonly used smart drugs or nootropics called Provigil (modafinil) and Nuvigil (armodafinil) have been linked to increased risk of congenital malformations in newborns, such as wryneck, hypospadias, and congenital heart defects. Researchers advise avoiding these drugs during pregnancy.

A new survey has found that 47% of British women do not self-examine their breast for any potential signs of breast cancer. Most women said they forget to do, while others said they were embarrassed to d so or they did not want to trouble their GPs.

On Friday, AstraZeneca said it resumed the late-stage clinical trial of its experimental COVID-19 vaccine in the United States. The trial was suspended after researchers reported a serious neurological disorder, called transverse myelitis, in one of the participants.

The BMJ associated editor, Peter Doshi, has recently said that the ongoing Phase III or late-stage trials are not designated to tell us whether they will save lives. He also raised concerns over why the trials are not assessing the vaccine’s efficacy for severe COVID-19 infection and in the elderly, children, pregnant women, and immunocompromised people.